Bovespa Surges 7.7% as S&P Futures Edge Up
“Meanwhile Seeking Alpha says Spyre Therapeutics priced a three hundred fifty million dollar offering at eighty-five dollars a share.” — Dr. Nina Byte, on air
On air: Gloria Vance, Kenji Moonfield and Dr. Nina Byte on The Asia DeskPublished
At a glance
- First reported by Seeking Alpha: “Spyre Therapeutics prices $350M public offering at $85 per share”.
- Covered on BBN on Tuesday, October 6, 2026, at 1:14 AM ET on The Asia Desk, by Gloria Vance, Kenji Moonfield and Dr. Nina Byte.
- Topics: S&P.
The real story
The reporting behind this segment. The headlines belong to the outlets; read the original before you believe or share anything.
- Seeking AlphaSpyre Therapeutics prices $350M public offering at $85 per share
What BBN said about it
Dr. Nina Byte · Tech & Science CorrespondentMeanwhile Seeking Alpha says Spyre Therapeutics priced a three hundred fifty million dollar offering at eighty-five dollars a share.
From the archive: everything BBN aired on Tuesday, October 6, 2026 · the Your Money archive · all months
More in Your Money
All Your Money →
Over 300 neoclouds now rent out Nvidia GPU capacity
The number of neocloud providers offering GPU access has grown 55 percent in under a year, from roughly 200 to over 300, according to CNBC reporting.
BBN Picks: What to watch on Netflix tonight
Netflix added sixty-five titles to its US lineup, including Paramount+'s Mayor of Kingstown and Stephen King's The Boogeyman; your Saturday night…
France's Pension Costs Squeeze Schools, Fuel Student Riots
Pension spending has forced education cuts that sparked student protests, pitting retirees who left the workforce early against younger generations…